Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Blute

Showing results (1-10 of 295) with videos related to

Pageof 30
Sort By:
European Urology|December 9, 2008
Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathologyMichael L Blute
The Journal of Urology|April 18, 2009
No proof of inferiority: open radical retropubic prostatectomy remains state-of-the-art surgical technique for localized prostate cancerMichael L Blute
Urology|September 3, 2011
Editorial commentMichael L Blute
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Radical prostatectomy by open or laparoscopic/robotic techniques: an issue of surgical device or surgical expertise?Michael L Blute
The Journal of Urology|February 23, 2010
Editorial commentMichael L Blute
Urology|July 2, 2009
Editorial commentMichael L Blute
Nature Clinical Practice. Urology|March 22, 2007
Nephron-sparing surgery: the 'gold standard' treatment for small renal cortical tumorsMichael L Blute
Mayo Clinic Proceedings|March 11, 2004
Defining the appropriate patient population for primary brachytherapy for localized prostate cancer: work in progressIgor Frank, Michael L Blute
The Journal of Urology|January 10, 2004
Re: Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the Search databaseMichael L Blute, Erik Bergstralh
Urology|March 15, 2006
The management of superficial transitional cell carcinoma of the bladderShomik Sengupta, Michael L Blute
Pageof 30

Showing results (1-10 of 295) with videos related to

Sort By:
Pageof 30
European Urology|December 9, 2008
Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathologyMichael L Blute
The Journal of Urology|April 18, 2009
No proof of inferiority: open radical retropubic prostatectomy remains state-of-the-art surgical technique for localized prostate cancerMichael L Blute
Urology|September 3, 2011
Editorial commentMichael L Blute
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Radical prostatectomy by open or laparoscopic/robotic techniques: an issue of surgical device or surgical expertise?Michael L Blute
The Journal of Urology|February 23, 2010
Editorial commentMichael L Blute
Urology|July 2, 2009
Editorial commentMichael L Blute
Nature Clinical Practice. Urology|March 22, 2007
Nephron-sparing surgery: the 'gold standard' treatment for small renal cortical tumorsMichael L Blute
Mayo Clinic Proceedings|March 11, 2004
Defining the appropriate patient population for primary brachytherapy for localized prostate cancer: work in progressIgor Frank, Michael L Blute
The Journal of Urology|January 10, 2004
Re: Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the Search databaseMichael L Blute, Erik Bergstralh
Urology|March 15, 2006
The management of superficial transitional cell carcinoma of the bladderShomik Sengupta, Michael L Blute
Pageof 30